Literature DB >> 30685796

The mean striatal 18F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma.

Francesco Cicone1, Luciano Carideo2, Giuseppe Minniti3,4, Francesco Scopinaro2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30685796     DOI： 10.1007/s00259-019-4276-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

1.  Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.

Authors:  Johannes Schwarzenberg; Johannes Czernin; Timothy F Cloughesy; Benjamin M Ellingson; Whitney B Pope; Tristan Grogan; David Elashoff; Cheri Geist; Daniel H S Silverman; Michael E Phelps; Wei Chen
Journal:  Clin Cancer Res       Date:  2014-03-31       Impact factor: 12.531

2.  Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.

Authors:  Ken Herrmann; Johannes Czernin; Timothy Cloughesy; Albert Lai; Kelsey L Pomykala; Matthias R Benz; Andreas K Buck; Michael E Phelps; Wei Chen
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

Review 3.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

4.  Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.

Authors:  Giovanni Morana; Arnoldo Piccardo; Domenico Tortora; Matteo Puntoni; Mariasavina Severino; Paolo Nozza; Marcello Ravegnani; Alessandro Consales; Samantha Mascelli; Alessandro Raso; Manlio Cabria; Antonio Verrico; Claudia Milanaccio; Andrea Rossi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-27       Impact factor: 9.236

5.  Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.

Authors:  Francesco Cicone; Christian P Filss; Giuseppe Minniti; Camilla Rossi-Espagnet; Annalisa Papa; Claudia Scaringi; Norbert Galldiks; Alessandro Bozzao; N Jon Shah; Francesco Scopinaro; Karl-Josef Langen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-07       Impact factor: 9.236

6.  IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas.

Authors:  A Verger; Ph Metellus; Q Sala; C Colin; E Bialecki; D Taieb; O Chinot; D Figarella-Branger; E Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-14       Impact factor: 9.236

7.  18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.

Authors:  Wei Chen; Daniel H S Silverman; Sibylle Delaloye; Johannes Czernin; Nirav Kamdar; Whitney Pope; Nagichettiar Satyamurthy; Christiaan Schiepers; Timothy Cloughesy
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

8.  18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.

Authors:  Sellam Karunanithi; Punit Sharma; Abhishek Kumar; Bangkim Chandra Khangembam; Guru Pada Bandopadhyaya; Rakesh Kumar; Deepak Kumar Gupta; Arun Malhotra; Chandrasekhar Bal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-23       Impact factor: 9.236

9.  Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.

Authors:  Maria C Rossi Espagnet; Andrea Romano; Valeria Mancuso; Francesco Cicone; Antonio Napolitano; Claudia Scaringi; Giuseppe Minniti; Alessandro Bozzao
Journal:  Br J Radiol       Date:  2016-08-09       Impact factor: 3.039

10.  Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.

Authors:  Deanna H Pafundi; Nadia N Laack; Ryan S Youland; Ian F Parney; Val J Lowe; Caterina Giannini; Brad J Kemp; Michael P Grams; Jonathan M Morris; Jason M Hoover; Leland S Hu; Jann N Sarkaria; Debra H Brinkmann
Journal:  Neuro Oncol       Date:  2013-03-03       Impact factor: 12.300
View more
  5 in total

1.  Combining 18F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study.

Authors:  Antoine Girard; Pierre-Jean Le Reste; Alice Metais; Beatrice Carsin Nicol; Dan Cristian Chiforeanu; Elise Bannier; Boris Campillo-Gimenez; Anne Devillers; Xavier Palard-Novello; Florence Le Jeune
Journal:  J Neurooncol       Date:  2021-10-22       Impact factor: 4.130

2.  Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET.

Authors:  Francesco Cicone; Luciano Carideo; Claudia Scaringi; Andrea Romano; Marcelo Mamede; Annalisa Papa; Anna Tofani; Giuseppe Lucio Cascini; Alessandro Bozzao; Francesco Scopinaro; Giuseppe Minniti
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

3.  Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas.

Authors:  Hiroyuki Tatekawa; Akifumi Hagiwara; Hiroyuki Uetani; Jingwen Yao; Talia C Oughourlian; Shadfar Bahri; Chencai Wang; Catalina Raymond; Albert Lai; Timothy F Cloughesy; Phioanh L Nghiemphu; Linda M Liau; Whitney B Pope; Noriko Salamon; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2020-09-14       Impact factor: 4.130

4.  Dynamic 18F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?

Authors:  Timothée Zaragori; Matthieu Doyen; Fabien Rech; Marie Blonski; Luc Taillandier; Laëtitia Imbert; Antoine Verger
Journal:  Front Oncol       Date:  2021-10-05       Impact factor: 6.244

5.  Correlation of multimodal 18F-DOPA PET and conventional MRI with treatment response and survival in children with diffuse intrinsic pontine gliomas.

Authors:  Giovanni Morana; Domenico Tortora; Gianluca Bottoni; Matteo Puntoni; Gianluca Piatelli; Federica Garibotto; Salvina Barra; Flavio Giannelli; Angelina Cistaro; Mariasavina Severino; Antonio Verrico; Claudia Milanaccio; Maura Massimino; Maria Luisa Garrè; Andrea Rossi; Arnoldo Piccardo
Journal:  Theranostics       Date:  2020-10-25       Impact factor: 11.556
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.